盛禾生物-B(02898)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02898 盛禾生物-B

停牌 04-30 15:16:34

6.390

+0.000

0.00%

最高6.390	最低6.390	成交量0.00
今开6.390	昨收6.390	日振幅0.00%
总市值10.03亿	流通市值10.01亿	总股本1.57亿
成交额0.00	换手率0.00%	流通股本1.57亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02898","market":"HK","secType":"STK","nameCN":"盛禾生物-B","latestPrice":6.39,"timestamp":1777512013278,"preClose":6.39,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":156666800,"shares":157000000,"eps":-0.623669,"marketStatus":"停牌","change":0,"latestTime":"04-30 15:16:34","open":6.39,"high":6.39,"low":6.39,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.59602,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1777536600000},"marketStatusCode":2,"adr":0,"listingDate":1716480000000,"exchange":"SEHK","adjPreClose":6.39,"openAndCloseTimeList":[[1777512600000,1777521600000],[1777525200000,1777536000000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02898","defaultTab":"news","newsList":[{"id":"1183029846","title":"盛禾生物-B更新3月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1183029846","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183029846?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:51","pubTimestamp":1775724681,"startTime":"0","endTime":"0","summary":"盛禾生物控股有限公司（盛禾生物-B）于2026年4月9日公布2026年3月股份变动月报表。本报告期自2026年3月1日至3月31日，以下为本期主要信息。\n公告显示，本月公司法定注册股本为2亿股，每股面值0.0005美元，总额维持在10万美元，与上月持平。截至本月末，公司已发行普通股数量为156,666,800股，未有新增发行、购回或注销活动，股本结构保持不变。\n公司同时确认，当前已符合适用的公众持股量要求，未出现任何违规情形。公告由主席兼执行董事张峰签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624568414","title":"盛禾生物-B(02898)4月1日起停牌 待刊发2025年全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2624568414","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624568414?lang=zh_cn&edition=full","pubTime":"2026-04-01 10:18","pubTimestamp":1775009939,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盛禾生物-B(02898)发布公告，公司股份将于2026年4月1日(星期三)上午九时正起在联交所暂停买卖，直至公司刊发有关2025年年度业绩的公告为止。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423751.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02898","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623104355","title":"盛禾生物-B(02898)：延迟刊发2025年年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2623104355","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623104355?lang=zh_cn&edition=full","pubTime":"2026-03-29 18:51","pubTimestamp":1774781499,"startTime":"0","endTime":"0","summary":"基于上述情况，董事会预见公司将无法按照上市规则第13.49条的规定刊发2025年年度业绩。根据上市规则第13.50条，倘发行人未能按照上市规则刊发定期财务资料，联交所通常会要求暂停买卖发行人证券，且该暂停通常将持续至发行人刊发载有所需财务资料的公告为止。据此，目前预期公司股份将于2026年4月1日上午9时正起在联交所暂停买卖，直至公司公布2025年年度业绩为止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421371.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02898","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620440879","title":"盛禾生物-B(02898.HK)拟3月27日举行董事会会议审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2620440879","media":"中金财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620440879?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:07","pubTimestamp":1773738426,"startTime":"0","endTime":"0","summary":"格隆汇3月17日丨盛禾生物-B(02898.HK)宣布，公司将于2026年3月27日(星期五)举行董事会会议，藉以(其中包括)考虑及批准集团截至2025年12月31日止年度业绩及其刊发，考虑派发末期股息(如有)并处理任何其他事务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260317/32074864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02898","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181870903","title":"盛禾生物(02898)2月股份变动月报表：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1181870903","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181870903?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:01","pubTimestamp":1772442099,"startTime":"0","endTime":"0","summary":"盛禾生物控股有限公司（02898）于2026年3月2日披露截至2026年2月28日的股份变动月报表。公告显示，公司在报告期内注册股本维持在200,000,000股，面值为每股USD 0.0005，对应注册股本总额USD 100,000。\n公司已发行股份总数自上月底以来无新增或减少，仍为156,666,800股，未有购回或注销股份行为。公告同时显示，公司当前公众持股量符合适用的最低比例要求。\n公司于期内并无期权、可换股票据、权证或其他股份激励计划的变动。整体来看，截至2月底，盛禾生物控股有限公司无新增发行或股份变动，股本结构保持稳定。\n公告由公司主席兼执行董事张峰签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614834513","title":"盛禾生物-B股价重挫16.67% 市值跌1.44亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614834513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614834513?lang=zh_cn&edition=full","pubTime":"2026-02-27 11:59","pubTimestamp":1772164795,"startTime":"0","endTime":"0","summary":"2026年02月27日临近午盘11时59分，盛禾生物-B股票出现异动，股价大幅跳水16.67%。截至发稿，该股报5.500港元/股，成交量600股，换手率0.00%，振幅0.00%。盛禾生物-B股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，药明合联、康希诺生物、三叶草生物-B涨幅较大，振幅较大的相关个股有创胜集团-B、翰思艾泰-B、科济药业-B，振幅分别为9.88%、9.20%、8.42%。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单克隆抗体,IAP0971及IAE0972均为抗体细胞因子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022711595595423118&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022711595595423118&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614775130","title":"盛禾生物-B盘中异动 股价大跌14.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614775130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614775130?lang=zh_cn&edition=full","pubTime":"2026-02-25 09:49","pubTimestamp":1771984154,"startTime":"0","endTime":"0","summary":"2026年02月25日早盘09时49分，盛禾生物-B股票出现波动，股价快速跳水14.08%。截至发稿，该股报5.490港元/股，成交量400股，换手率0.00%，振幅0.00%。盛禾生物-B股票所在的生物技术行业中，整体跌幅为0.64%。盛禾生物-B公司简介：Sunho Biologics Inc是一家临床阶段的生物制药公司,主要致力于发现、开发和商业化用于治疗癌症和自身免疫性疾病的生物制剂。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单克隆抗体,IAP0971及IAE0972均为抗体细胞因子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602250949149541df75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602250949149541df75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02898","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612252506","title":"IO2.0争夺战打响，下一代肿瘤“药王”花落谁家？","url":"https://stock-news.laohu8.com/highlight/detail?id=2612252506","media":"药创新","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612252506?lang=zh_cn&edition=full","pubTime":"2026-02-20 15:00","pubTimestamp":1771570819,"startTime":"0","endTime":"0","summary":"下一代肿瘤“药王”争夺战打响！撰文丨粽哥2025下一代肿瘤“药王”，极有可能诞生于PD-1+X领域。以K药为代表的PD-1单抗，开启了一代IO治疗时代，但却存在耐药和冷肿瘤缺乏应答的问题。临床上，T细胞耗竭现象是导致免疫检查点获得性耐药的关键机制。TIGIT是经典免疫逃逸靶点，在多种淋巴细胞上表达，被认为是“下一个PD-1”。不过，PD-1/TIGIT双抗或有望打破TIGIT“难以成药”的魔咒。TIGIT和PD-1表达之间存在很强的相关性，特别是在肺癌的肿瘤浸","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602201513389541818d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602201513389541818d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2778985437.USD","LU0348735423.USD","09995","LU0348827113.USD","02898","LU0417516738.SGD","LU2399975544.HKD","09926","BK1574","01177","01530","02616","LU0348825331.USD","LU0634319403.HKD","IE00BPRC5H50.USD","LU0561508036.HKD","09887","LU2476274308.USD","LU2476274720.SGD","LU0348766576.USD","BK1161","LU1794554557.SGD","01877","IE00B5MMRT66.SGD","LU2488822045.USD","02696","LU0348784397.USD","LU0540923850.HKD","LU0417516902.SGD","01801","LU0348783233.USD","IE00B543WZ88.USD","LU1720050803.USD","LU0348767384.USD","LU1961090484.USD","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2610947979","title":"盛禾生物-B盘中异动 早盘急速下挫8.66%报5.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610947979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610947979?lang=zh_cn&edition=full","pubTime":"2026-02-12 10:15","pubTimestamp":1770862521,"startTime":"0","endTime":"0","summary":"2026年02月12日早盘10时15分，盛禾生物-B股票出现异动，股价急速下跌8.66%。截至发稿，该股报5.800港元/股，成交量400股，换手率0.00%，振幅0.00%。资金方面，该股资金流入0港元，流出0港元。盛禾生物-B股票所在的生物技术行业中，整体涨幅为0.10%。该公司拥有三种核心产品,即IAH0968、IAP0971及IAE0972。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单克隆抗体,IAP0971及IAE0972均为抗体细胞因子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021210152297a5dea9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021210152297a5dea9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02898","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161358124","title":"盛禾生物控股（02898）公布2026年1月月报，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1161358124","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161358124?lang=zh_cn&edition=full","pubTime":"2026-02-04 17:36","pubTimestamp":1770197786,"startTime":"0","endTime":"0","summary":"盛禾生物控股有限公司近日发布2026年1月证券变动月报表。公告日期为2026年2月4日，报告期覆盖至2026年1月31日。根据公告显示，公司法定股本维持为2亿股，面值每股0.0005美元，注册资本总额100,000美元；截至本月底已发行股份总数为156,666,800股，与上月底一致。截至报告期末，股本结构未发生实质变动，公众持股量符合适用的香港联交所上市规则要求。公告由公司主席兼执行董事张峰签署。公司表示将持续遵守香港联交所《上市规则》及相关法规之规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606322246","title":"盛禾生物委任姜晓玲为CEO兼首席科学官，履历涵盖金斯瑞、优科制药","url":"https://stock-news.laohu8.com/highlight/detail?id=2606322246","media":"瑞财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606322246?lang=zh_cn&edition=full","pubTime":"2026-01-26 18:30","pubTimestamp":1769423411,"startTime":"0","endTime":"0","summary":"瑞财经 刘治颖1月23日，盛禾生物-B公告，执行董事姜晓玲已获委任为公司首席执行官兼首席科学官，自2026年1月23日起生效。资料显示，姜晓玲，自2020年2月起加入集团，担任盛禾（中国）生物制药的副总经理及研发负责人。2024年，姜晓玲获得薪金及其他福利29.3万元，退休福利计划供款1万元，酌情花红4.5万元及股权支付236.2万元。2025年上半年，盛禾生物其他收入为503.5万元，同比增长182.55%；期内亏损为3819.9万元，上年同期亏损3607.7万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126183034a4573dc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126183034a4573dc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","HK0000306701.USD","BK1161","01548","HK0000320223.HKD","HK0000320264.USD","01477","BK1583","BK1141","HK0000306685.HKD","BK1576","BK1191","02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605477190","title":"盛禾生物-B(02898)：姜晓玲获委任为首席执行官兼首席科学官","url":"https://stock-news.laohu8.com/highlight/detail?id=2605477190","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605477190?lang=zh_cn&edition=full","pubTime":"2026-01-23 20:32","pubTimestamp":1769171578,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盛禾生物-B(02898)发布公告，执行董事姜晓玲女士已获委任为公司首席执行官兼首席科学官，自2026年1月23日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02898","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605244011","title":"盛禾生物-B盘中异动 早盘股价大跌10.33%报6.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605244011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605244011?lang=zh_cn&edition=full","pubTime":"2026-01-23 09:58","pubTimestamp":1769133505,"startTime":"0","endTime":"0","summary":"2026年01月23日早盘09时58分，盛禾生物-B股票出现波动，股价快速跳水10.33%。截至发稿，该股报6.250港元/股，成交量1800股，换手率0.00%，振幅0.14%。资金方面，该股资金流入0港元，流出1.1266万港元。盛禾生物-B股票所在的生物技术行业中，整体涨幅为0.92%。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单克隆抗体,IAP0971及IAE0972均为抗体细胞因子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123095825953dfe79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123095825953dfe79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02898","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604368161","title":"盛禾生物-B(02898)：殷刘松辞任执行董事、首席执行官兼首席科学官","url":"https://stock-news.laohu8.com/highlight/detail?id=2604368161","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604368161?lang=zh_cn&edition=full","pubTime":"2026-01-19 21:10","pubTimestamp":1768828219,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盛禾生物-B(02898)发布公告，殷刘松博士已于2026年1月19日提出辞任公司执行董事、首席执行官兼首席科学官，自2026年2月28日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"盛禾生物-B(02898)：殷刘松辞任执行董事、首席执行官兼首席科学官","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111364007","title":"盛禾生物控股（02898）更新2025年12月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1111364007","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111364007?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:35","pubTimestamp":1767342926,"startTime":"0","endTime":"0","summary":"盛禾生物控股有限公司于2026年1月2日公布2025年12月的股份变动月报表。报告显示，截至2025年12月31日，公司注册股本维持在200,000,000股，每股面值USD 0.0005，合计注册股本USD 100,000，未见任何增减。同时，公告显示，本月无任何股份期权、可换股票据或其他相关激励计划的变动。整体而言，截至2025年12月31日，盛禾生物控股有限公司股本总数保持不变，公司声明遵守了香港联交所《上市规则》及相关法律规定。上述月报由公司主席兼执行董事张峰签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588046853","title":"盛禾生物-B盘中异动 早盘急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588046853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588046853?lang=zh_cn&edition=full","pubTime":"2025-12-03 10:38","pubTimestamp":1764729509,"startTime":"0","endTime":"0","summary":"2025年12月03日早盘10时38分，盛禾生物-B股票出现异动，股价大幅拉升5.07%。截至发稿，该股报7.250港元/股，成交量4400股，换手率0.00%，振幅2.46%。盛禾生物-B股票所在的生物技术行业中，整体跌幅为1.46%。其相关个股中，中生北控生物科技、盛禾生物-B、嘉和生物-B涨幅较大，振幅较大的相关个股有中生北控生物科技、华康生物医学、歌礼制药-B，振幅分别为14.98%、10.87%、10.30%。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单株抗体,IAP0971及IAE0972均为抗体细胞激素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203103829a7206997&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203103829a7206997&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586267959","title":"盛禾生物-B11月26日主力净流出12.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2586267959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586267959?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:15","pubTimestamp":1764144922,"startTime":"0","endTime":"0","summary":"11月26日, 盛禾生物-B股价跌1.57%，报收6.88元，成交金额25.2万元，换手率0.02%，振幅10.30%，量比8.80。盛禾生物-B今日主力资金净流出12.8万元，上一交易日主力净流出0万元。该股近5个交易日下跌8.14%，主力资金累计净流出12.8万元；近20日主力资金累计净流出12.8万元，其中净流出天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112616165197804a86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112616165197804a86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586474417","title":"盛禾生物-B盘中异动 急速下挫5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586474417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586474417?lang=zh_cn&edition=full","pubTime":"2025-11-25 15:55","pubTimestamp":1764057326,"startTime":"0","endTime":"0","summary":"2025年11月25日临近收盘15时55分，盛禾生物-B股票出现异动，股价大幅下挫5.92%。盛禾生物-B股票所在的生物技术行业中，整体跌幅为1.17%。其相关个股中，拨康视云-B、绿竹生物-B、中生北控生物科技涨幅较大，振幅较大的相关个股有中生北控生物科技、拨康视云-B、华康生物医学，振幅分别为22.54%、20.38%、16.90%。该公司拥有三种核心产品,分别为IAH0968、IAP0971及IAE0972。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单株抗体,IAP0971及IAE0972均为抗体细胞激素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125155526977e22df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125155526977e22df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517505109","title":"盛禾生物-B03月07日主力净流出5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517505109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517505109?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:17","pubTimestamp":1741335429,"startTime":"0","endTime":"0","summary":"03月07日, 盛禾生物-B股价跌5.35%，报收3.89元，成交金额7万元，换手率0.01%，振幅4.87%，量比6.56。盛禾生物-B今日主力资金净流出5万元，上一交易日主力净流出0万元。该股近5个交易日下跌7.60%，主力资金累计净流出5万元；近20日主力资金累计净流出5万元，其中净流出天数为1日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170958abecca1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170958abecca1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02898"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514812787","title":"盛禾生物-B盘中异动 早盘股价大涨6.25%报4.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514812787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514812787?lang=zh_cn&edition=full","pubTime":"2025-02-27 10:45","pubTimestamp":1740624322,"startTime":"0","endTime":"0","summary":"2025年02月27日早盘10时45分，盛禾生物-B股票出现异动，股价大幅上涨6.25%。截至发稿，该股报4.250港元/股，成交量600股，换手率0.00%，振幅0.00%。资金方面，该股资金流入2550港元，流出0港元。盛禾生物-B股票所在的生物技术行业中，整体跌幅为0.64%。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单株抗体,IAP0971及IAE0972均为抗体细胞激素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227104522abde98d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227104522abde98d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02898"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.longruntea.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.0273},{"period":"6month","weight":-0.2013},{"period":"1year","weight":0.42},{"period":"ytd","weight":-0.0377}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.055},{"period":"3month","weight":-0.0664},{"period":"6month","weight":0.0079},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.0188}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Sunho Biologics Inc是一家主要从事生物技术的研发和生产的公司。该公司主要从事发现、开发和商业化生物制剂，通过直接调节先天性和适应性免疫系统来调节免疫微环境。该公司拥有三种核心产品，即IAH0968、IAP0971及IAE0972。IAH0968是一种抗体依赖性细胞介导的细胞毒性增强型单克隆抗体，IAP0971及IAE0972均为抗体细胞因子。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":-0.038899},{"month":2,"riseRate":0.4,"avgChangeRate":-0.004403},{"month":3,"riseRate":0.357143,"avgChangeRate":0.015388},{"month":4,"riseRate":0.333333,"avgChangeRate":0.011323},{"month":5,"riseRate":0.333333,"avgChangeRate":0.036651},{"month":6,"riseRate":0.266667,"avgChangeRate":0.072908},{"month":7,"riseRate":0.266667,"avgChangeRate":-0.002222},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.068577},{"month":9,"riseRate":0.214286,"avgChangeRate":-0.012573},{"month":10,"riseRate":0.266667,"avgChangeRate":0.020492},{"month":11,"riseRate":0.466667,"avgChangeRate":0.037807},{"month":12,"riseRate":0.4,"avgChangeRate":0.03045}],"exchange":"SEHK","name":"盛禾生物-B","nameEN":"SUNHO BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盛禾生物-B(02898)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盛禾生物-B(02898)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盛禾生物-B,02898,盛禾生物-B股票,盛禾生物-B股票老虎,盛禾生物-B股票老虎国际,盛禾生物-B行情,盛禾生物-B股票行情,盛禾生物-B股价,盛禾生物-B股市,盛禾生物-B股票价格,盛禾生物-B股票交易,盛禾生物-B股票购买,盛禾生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盛禾生物-B(02898)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盛禾生物-B(02898)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}